Dr. Manu Sebastian joins OptraSCAN’s Medical Advisory Board
San Jose, CA, September 17th, 2019: OptraSCAN®, the leading On-Demand Digital Pathology solution provider today announced that Dr. Manu Sebastian, Associate Professor & Director – The University of Texas MD Anderson Cancer Center (MDACC) has joined as a member of OptraSCAN’s Medical Advisory Board. Dr. Sebastian is board certified by American College of Veterinary Pathology, American College of Toxicology and American College of Laboratory Animal Medicine with more than 20 years of experience in both academia and biopharmaceutical industry.
Dr. Sebastian held faculty positions in University of Georgia, Cornell University and Columbia University, where he was the Chief of Comparative Pathology. His primary interest is translational pathology in cancer with special interest in cancer drug discovery. He has extensive experience in pharmaceutical & medical devices efficacy studies, safety evaluation and regulatory approval. After working for 6 years in biotech industry, he joined MDACC in August 2016. The core he manages in MDACC provides image analysis for both research and drug discovery.
Dr. Manu Sebastian
“I am excited to join the advisory board at OptraSCAN. OptraSCAN is one of those few medical devices companies that are committed in providing affordable digital pathology solutions not only to humans but also to veterinary research. I look forward to contributing to Medical Advisory Board’s efforts”, said Dr. Manu Sebastian.
“I welcome Dr. Sebastian to our Medical Advisory Board. Under his guidance, OptraSCAN aims to streamline VetPath and Histology workflows, improving turnaround time for customers. The use of OptraSCAN web / mobile tools will provide flexibility in day-to-day operations and give veterinarians easy access to domain experts, including IHC, oncology, and dermatology”, said Abhi Gholap, Founder & CEO, OptraSCAN.
OptraSCAN’s Medical Advisory Board comprise of Dr. Jiaoti Huang, Chair at Duke University and serves as the Chairman of OptraSCAN’s medical advisory board; Dr. Thomas J. Montine, Chair of Pathology at Stanford University School of Medicine; Dr. Abul Abbas, Chair, Department of Pathology, University of California San Francisco; Dr. Jon S. Morrow, Chair – Pathology at Yale School of Medicine and Dr. Allen Gown, Medical Director at PhenoPath Laboratories.
About OptraSCAN®:
An ISO 13485 certified company and CE marked whole slide scanners for IVD use, OptraSCAN® has developed world’s first ‘On-Demand Digital Pathology’ System; focused on delivering fully integrated, affordable systems & solutions. These serve as the perfect tool for transition from conventional microscopy to Digital Pathology for the effective acquisition of whole slide images, viewing, storing, real time sharing, and reporting via On-Demand or outright purchase model. Follow Us on LinkedIn and Twitter
Media Inquiries Contact:
Shruti Soman | Manager – Marketing Communications | 91.20.66540900 x 231 | s.soman@optraventures.com
Source: OptraScan
